News & Trends - Pharmaceuticals

Australia leading worldwide effort to eliminate Hepatitis C by 2030

Health Industry Hub | July 28, 2020 |
[Total: 1    Average: 4/5]

Pharma News: Today, on World Hepatitis Day, Gilead Sciences welcomes the findings of an independent global report that has revealed Australia is one of 10 countries working towards the World Health Organisation’s (WHO) goal to eliminate HCV by 2030.

The new report titled “Winning the Race to Eliminate Hepatitis C”, assessed the current status of HCV elimination in 29 high-income countries, covering Europe, Australia, and Canada. While profiling the significant progress made to date, including in Australia, the report recognises momentum is slowing, and a renewed political focus, alongside increased investment and dedicated resources are required if we are going to achieve disease elimination.

Jaime McCoy, General Manager, Gilead Sciences Australia commented: “The visionary and proactive approach taken here in Australia, has resulted in over 85,000 Australians being treated and cured of their hepatitis C. In particular, the decisive action by the Australian Government to enable universal reimbursed access to DAA treatment has significantly reduced the burden of HCV in Australia.”

“However, there are an estimated 130,000 people still living with HCV in Australia, with 600 dying from preventative conditions like liver disease every year. World Hepatitis Day is not only an opportunity to reflect on the considerable progress achieved to date, but all to reaffirm our efforts to maintaining momentum to eliminate HCV in Australia”, said Ms. McCoy.

The Report highlights challenges facing key at-risk groups, including people who inject drugs, migrants and indigenous communities, and outlines the hallmarks of a successful model of care including the implementation of a test-and-treat model to eliminate gaps between diagnosis and treatment. The innovative Queensland-based Kombi Clinic program is profiled in the Report as one of the best in the world for reaching at-risk groups and successfully facilitating treatment.

Ms. McCoy said “There is global recognition that one of the strengths of Australia’s response has been partnerships and the willingness of policymakers to prioritise and invest in HCV resources. At Gilead, we are proud of our role to date and are committed to collaborating across our sector to ensure we can eliminate this debilitating and deadly disease.”

Today, 28 July 2020, is World Hepatitis Day. It is a global initiative that aims to raise global awareness of hepatitis and encourage prevention, diagnosis and treatment.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Marketing & Strategy

Marketing Pharma Biotech Healthcare - PRIME Awards 2020 finalists announced

PRIME Awards 2020 finalists announced

Health Industry Hub | August 7, 2020 |

The finalists for PRIME Awards 2020 have been named, with winners to be announced via a virtual ceremony on Thursday […]

More


News & Trends - Pharmaceuticals

Pharma News - New Ventolin inhalers with dose counter reimbursed on the PBS

New Ventolin inhalers with dose counter reimbursed on the PBS

Health Industry Hub | August 7, 2020 |

Pharma News: GSK Australia is pleased to announce that a dose counter has been added to VENTOLIN (salbutamol sulfate) metered […]

More


News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More